← All trials
NCT06442566
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 12, 2024
- Primary completion
- Mar 31, 2028
- Completion date
- Mar 31, 2029
- First posted
- Jun 4, 2024
- Last posted
- Oct 26, 2024
- Enrollment
- 240
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Medical University of South CarolinaLead sponsor
- Medical University of South CarolinaOfficial
- Medical University of South CarolinaSponsor investigator
- National Institute on Drug Abuse (NIDA)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.